With Bitcoin reaching record levels this year, Strategy's stock has benefited from the growing popularity of the top ...

FILE PHOTO: Renault Group's CEO Luca de Meo and Francois Provost, Chief Purchasing Officer and Managing Director of APO at ...

For me, my big lesson came in the global financial crisis. I was young enough to be reckless, but old enough to have known ...

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people around the world achieve their ...

CFO Pecoraro detailed the future repricing schedule, noting approximately $75 million of loans set to reprice in 2026 at a ...

Growth in marketing spend is an “implicit recognition” Unilever’s investment three years ago was “absolutely uncompetitive”, ...

As more Bank of England (BoE) interest rate cuts are expected to take place over the second half of 2025, it’s time to assess ...

The majority of absolute bank performance can be explained by four key factors. The post Investing in ASX 200 banks: Which ...

The London Company, an investment management company, released “The London Company Mid Cap Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here.

The majority of Teva's business lies in generic and off-patent branded drugs which faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...